• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪肝疾病逐渐恶化为肝癌,抑制参与能量依赖性紊乱、细胞衰老和慢性炎症的AMPK信号通路。

Gradual deterioration of fatty liver disease to liver cancer inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation.

作者信息

Meng Sha-Sha, Gu Hong-Wei, Zhang Ting, Li Yu-Sang, Tang He-Bin

机构信息

Laboratory of Hepatopharmacology and Ethnopharmacology, School of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, China.

Department of Pharmacy, Wuhan Mental Health Center, Wuhan, China.

出版信息

Front Oncol. 2023 Mar 2;13:1099624. doi: 10.3389/fonc.2023.1099624. eCollection 2023.

DOI:10.3389/fonc.2023.1099624
PMID:36937390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10018212/
Abstract

INTRODUCTION

Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5'-AMP-activated protein kinase (AMPK) is strongly linked to alterations in the tumor microenvironment, such as inflammation, hypoxia, and aging. The objective of this study is to evaluate the impact of the AMPK signaling pathway on the progression of fatty liver to HCC.

METHODS

In this study, we established a mouse liver cancer model using high-fat diets and nano-nitrosamines (nano-DEN). In addition, we employed a transcriptomic technique to identify all mRNAs detected in liver samples at the 25th weekexpression of proteins linked with the LKB1-AMPK-mTOR signaling pathway, inflammation, aging, and hypoxia was studied in microarrays of liver cancer tissues from mice and humans. These proteins included p-AMPK, LKB1, mTOR, COX-2, β-catenin, HMGB1, p16, and HIF-1α.

RESULTS

Data were collected at different times in the liver as well as in cancerous and paracancerous regions and analyzed by a multispectral imaging system. The results showed that most of the genes in the AMPK signaling pathway were downregulated. expression was upregulated compared to control group but downregulated in the cancerous regions compared to the paracancerous regions. expression was downregulated in the cancerous regions. expression was upregulated in the cancerous regions. During liver cancer formation, deletion of LKB1 in the LKB1-AMPK-mTOR signaling pathway reduces phosphorylation of AMPK. It contributed to the upregulation of mTOR, which further led to the upregulation of HIF1α. In addition, the expression of β-catenin, COX-2, and HMGB1 were upregulated, as well as the expression of p16 was downregulated.

DISCUSSION

These findings suggest that changes in the AMPK signaling pathway exacerbate the deterioration of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging in the tumor microenvironment, promoting the development of fatty liver into liver cancer.

摘要

引言

肝细胞癌(HCC)是最常见的原发性肝癌类型。根据最近的研究,脂肪肝会增加肝细胞癌的风险。然而,AMPK信号通路至关重要。此外,5'-AMP激活蛋白激酶(AMPK)与肿瘤微环境的改变密切相关,如炎症、缺氧和衰老。本研究的目的是评估AMPK信号通路对脂肪肝向HCC进展的影响。

方法

在本研究中,我们使用高脂饮食和纳米亚硝胺(纳米DEN)建立了小鼠肝癌模型。此外,我们采用转录组技术来鉴定在第25周时肝脏样本中检测到的所有mRNA。在小鼠和人类肝癌组织的微阵列中研究了与LKB1-AMPK-mTOR信号通路、炎症、衰老和缺氧相关的蛋白质表达。这些蛋白质包括p-AMPK、LKB1、mTOR、COX-2、β-连环蛋白、HMGB1、p16和HIF-1α。

结果

在肝脏以及癌组织和癌旁组织的不同时间收集数据,并通过多光谱成像系统进行分析。结果表明,AMPK信号通路中的大多数基因被下调。与对照组相比,其表达上调,但与癌旁组织相比,在癌组织中下调。其表达在癌组织中下调。其表达在癌组织中上调。在肝癌形成过程中,LKB1-AMPK-mTOR信号通路中LKB1的缺失会降低AMPK的磷酸化。这导致mTOR的上调,进而导致HIF1α的上调。此外,β-连环蛋白、COX-2和HMGB1的表达上调,以及p16的表达下调。

讨论

这些发现表明,AMPK信号通路的变化加剧了肿瘤微环境中能量代谢紊乱、慢性炎症、缺氧和细胞衰老的恶化,促进了脂肪肝向肝癌的发展。

相似文献

1
Gradual deterioration of fatty liver disease to liver cancer inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation.脂肪肝疾病逐渐恶化为肝癌,抑制参与能量依赖性紊乱、细胞衰老和慢性炎症的AMPK信号通路。
Front Oncol. 2023 Mar 2;13:1099624. doi: 10.3389/fonc.2023.1099624. eCollection 2023.
2
Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway.松柏醛通过 LKB1/AMPK 信号通路改善棕榈酸诱导的 HepG2 细胞的脂类和葡萄糖代谢。
J Food Sci. 2020 Nov;85(11):4050-4060. doi: 10.1111/1750-3841.15482. Epub 2020 Oct 10.
3
[Effect of electroacupuncture on hepatocyte autophagy and oxidative stress in SAMP8 mice by regulating AMPK/mTOR/ULK1 signaling pathway].[电针通过调节AMPK/mTOR/ULK1信号通路对SAMP8小鼠肝细胞自噬和氧化应激的影响]
Zhen Ci Yan Jiu. 2022 Jan 25;47(1):7-14. doi: 10.13702/j.1000-0607.201244.
4
Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.Naa20,NatB 复合物的催化亚基,通过调节 LKB1-AMPK-mTOR 轴促进肝细胞癌的发生。
Exp Mol Med. 2020 Nov;52(11):1831-1844. doi: 10.1038/s12276-020-00525-3. Epub 2020 Nov 20.
5
Metformin and cancer.二甲双胍与癌症。
Rev Diabet Stud. 2013 Winter;10(4):228-35. doi: 10.1900/RDS.2013.10.228. Epub 2014 Feb 10.
6
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.和厚朴酚通过 LKB1 依赖途径激活乳腺癌细胞中的 AMP 激活的蛋白激酶并抑制乳腺癌发生。
Breast Cancer Res. 2012 Feb 21;14(1):R35. doi: 10.1186/bcr3128.
7
Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.脂肪酸转运蛋白5(FATP5)缺乏通过重编程细胞能量代谢和调节AMPK-mTOR信号通路促进肝细胞癌的进展和转移。
Oncogenesis. 2021 Nov 12;10(11):74. doi: 10.1038/s41389-021-00364-5.
8
γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway.γ-亚麻酸通过 LKB1-AMPK-mTOR 通路平衡自噬和细胞凋亡来防止棕榈酸处理的 Alpha 鼠肝-12 细胞中的脂质代谢紊乱。
J Agric Food Chem. 2021 Jul 28;69(29):8257-8267. doi: 10.1021/acs.jafc.1c02596. Epub 2021 Jul 19.
9
Beneficial Effect of Nakai via the Activation of LKB1-AMPK Signaling Pathway on Obesity.中井通过激活LKB1-AMPK信号通路对肥胖的有益作用。
Evid Based Complement Alternat Med. 2021 Jan 17;2021:6655599. doi: 10.1155/2021/6655599. eCollection 2021.
10
Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.厚朴酚激活LKB1-AMPK信号通路并减轻肝细胞中的脂质积累。
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):113-24. doi: 10.1016/j.taap.2015.02.020. Epub 2015 Feb 28.

引用本文的文献

1
MMRN1 Facilitates Renal Cell Carcinoma by Activating AMPK/MMPs Axis.MMRN1通过激活AMPK/MMPs轴促进肾细胞癌。
Cancer Med. 2025 Jul;14(13):e71013. doi: 10.1002/cam4.71013.
2
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways.肿瘤进展中细胞衰老的调控与治疗靶点:机制与途径
Mol Cancer. 2025 Apr 2;24(1):106. doi: 10.1186/s12943-025-02284-z.
3
Involvement of SIRT1-mediated aging in liver diseases.SIRT1介导的衰老在肝脏疾病中的作用。

本文引用的文献

1
The AMPK pathway in fatty liver disease.脂肪肝疾病中的AMPK信号通路。
Front Physiol. 2022 Aug 25;13:970292. doi: 10.3389/fphys.2022.970292. eCollection 2022.
2
β-Catenin signaling in hepatocellular carcinoma.β-连环蛋白信号通路在肝癌中的作用。
J Clin Invest. 2022 Feb 15;132(4). doi: 10.1172/JCI154515.
3
TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.沉默 TRPM7 通过增强 AMPK 激活来促进 HIF-1α 降解,调节葡萄糖代谢重编程,从而抑制卵巢癌细胞生长。
Front Cell Dev Biol. 2025 Feb 20;13:1548015. doi: 10.3389/fcell.2025.1548015. eCollection 2025.
4
Mass spectrometry-based multi-omics analysis reveals distinct molecular features in early and advanced stages of hepatocellular carcinoma.基于质谱的多组学分析揭示了肝细胞癌早期和晚期不同的分子特征。
Heliyon. 2024 Sep 20;10(19):e38182. doi: 10.1016/j.heliyon.2024.e38182. eCollection 2024 Oct 15.
5
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.细胞衰老与代谢重编程:探索免疫抑制性肿瘤微环境中的复杂串扰。
Cancer Commun (Lond). 2024 Sep;44(9):929-966. doi: 10.1002/cac2.12591. Epub 2024 Jul 12.
6
Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis.通过孟德尔随机化分析阐明肠道微生物群与肝内胆管癌之间的因果关系。
Front Microbiol. 2023 Nov 14;14:1288525. doi: 10.3389/fmicb.2023.1288525. eCollection 2023.
7
Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.定量磷酸化蛋白质组学揭示人类早期原发性肝癌中的分子通路网络改变:3P医学方法的潜力
EPMA J. 2023 Aug 10;14(3):477-502. doi: 10.1007/s13167-023-00335-3. eCollection 2023 Sep.
J Exp Clin Cancer Res. 2022 Jan 31;41(1):44. doi: 10.1186/s13046-022-02252-1.
4
Ethanol supernatant extracts of Gynura procumbens could treat nanodiethylnitrosamine-induced mouse liver cancer by interfering with inflammatory factors for the tumor microenvironment.翻白草乙醇上清液提取物通过干预肿瘤微环境中的炎症因子治疗纳米二乙基亚硝胺诱导的小鼠肝癌。
J Ethnopharmacol. 2022 Mar 1;285:114917. doi: 10.1016/j.jep.2021.114917. Epub 2021 Dec 14.
5
Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.靶向抑制脂蛋白脂肪酶/脂肪酸结合蛋白4/肉碱棕榈酰转移酶1脂肪酸代谢轴可有效预防非酒精性脂肪性肝炎进展为肝癌。
Int J Biol Sci. 2021 Oct 11;17(15):4207-4222. doi: 10.7150/ijbs.64714. eCollection 2021.
6
Lactate in the tumour microenvironment: From immune modulation to therapy.肿瘤微环境中的乳酸:从免疫调节到治疗。
EBioMedicine. 2021 Nov;73:103627. doi: 10.1016/j.ebiom.2021.103627. Epub 2021 Oct 14.
7
Pathology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Pathologica. 2021 Jun;113(3):194-202. doi: 10.32074/1591-951X-242.
8
Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells.抑制SIRT1通过诱导肝癌干细胞衰老来限制自我更新和肿瘤发生。
J Hepatocell Carcinoma. 2021 Jun 29;8:685-699. doi: 10.2147/JHC.S296234. eCollection 2021.
9
ATE1 Inhibits Liver Cancer Progression through RGS5-Mediated Suppression of Wnt/β-Catenin Signaling.ATE1 通过 RGS5 介导的抑制 Wnt/β-连环蛋白信号通路抑制肝癌进展。
Mol Cancer Res. 2021 Sep;19(9):1441-1453. doi: 10.1158/1541-7786.MCR-21-0027. Epub 2021 Jun 22.
10
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.